CHGX — Chitogenx Income Statement
0.000.00%
Last trade - 00:00- CA$0.42m
- CA$4.60m
Annual income statement for Chitogenx, fiscal year end - January 31st, CAD millions except per share, conversion factor applied.
2020 January 31st | 2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 2.19 | 2.95 | 3.28 | 5.48 | 2.74 |
| Operating Profit | -2.19 | -2.95 | -3.28 | -5.48 | -2.74 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -2.49 | -3.77 | -4.92 | -6.23 | -1.55 |
| Net Income After Taxes | -2.49 | -3.77 | -4.92 | -6.23 | -1.55 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -2.49 | -3.77 | -4.92 | -6.23 | -1.55 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2.49 | -3.77 | -4.92 | -6.23 | -1.55 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.1 | -0.131 | -0.14 | -0.113 | -0.021 |